Nai-Kong V. Cheung
Affiliations: | Immunology | Harvard Medical School, Boston, MA, United States |
Google:
"Nai-Kong Cheung"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator| Richard J. O'Reilly | collaborator | (Cell & Gene Therapy Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Espinosa-Cotton M, Cheung NV. (2022) Bispecific antibodies for the treatment of neuroblastoma. Pharmacology & Therapeutics. 237: 108241 |
| Espinosa-Cotton M, Cheung NV. (2021) Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor. Frontiers in Oncology. 11: 772862 |
| Luo LY, Kramer K, Cheung NV, et al. (2020) Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma. Pediatric Blood & Cancer. e28364 |
| Park JA, Cheung NV. (2020) Targets and Antibody Formats for Immunotherapy of Neuroblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901410 |
| Santich BH, Park JA, Tran H, et al. (2020) Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Science Translational Medicine. 12 |
| Casey DL, Cheung NV. (2020) Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies. Cancer Immunology Research. 8: 161-166 |
| Wang L, Cheung NV, Hoseini SS, et al. (2019) Silencing Fc domains in T Cell-Engaging Bispecific Antibodies Improves T-Cell Trafficking and Antitumor Potency. Cancer Immunology Research |
| Pandit-Taskar N, Zanzonico PB, Kramer K, et al. (2019) Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Casey DL, Lin TY, Cheung NV. (2019) Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma. Frontiers in Oncology. 9: 537 |
| Bailey K, Pandit-Taskar N, Humm JL, et al. (2019) Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes. Journal of Neuro-Oncology |